Mitra Afshari is a Neurology physician affiliated with Rush University Medical Center. OpenAlex indexes 51 publications with 919 citations (h-index 13); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1725 W Harrison St Ste 1106
Chicago, IL 606123845
Telephone
312-942-4500Provider last certified this registry record 28 Mar 2025.
Clinical trials
- Telerehabilitation for Parkinson's Disease
Sponsor: Rush University Medical Center
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
7 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Abbott LaboratoriesProgram year20253 payments
- ABBVIE INC.Program year20253 payments
- Supernus Pharmaceuticals, Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
93.9%Aromatic Amino Acid Decarboxylation Inhibitor37.6%Carbidopa-Levodopa84%Carbidopa-Levodopa Er16%Part D≥89 patientsGabapentinoids9.6%Gabapentin100%Part D≥14 patients+ 12 more classes in this area
Cardiovascular
4.5%alpha-Adrenergic Agonist2.4%Midodrine Hcl100%Part D<11 patientsBeta blocker2.1%Propranolol Hcl100%Part D<11 patientsMusculoskeletal
1.6%gamma-Aminobutyric Acid-ergic Agonist1.6%Baclofen100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Loneliness in Parkinson's disease: Subjective experience overshadows objective motor impairment
Parkinsonism & Related Disorders
2025 - Participant and Provider Perspectives on a Novel Virtual Home Safety Program for Fall Prevention in Parkinson’s Disease
Journal of Clinical Medicine
2025 - Integrating tele-palliative care for atypical Parkinsonian disorders: Lessons learned from a pilot program
Clinical Parkinsonism & Related Disorders
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Christopher Goetz, MD
Rush University Medical Center
Theodore Pincus, MD
Rush University Medical Center
Christopher Seder, MD
Rush University Medical Center
Melody Cobleigh, MD
Rush University Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”